| Literature DB >> 27901112 |
Alan Van Goethem1,2, Nurten Yigit1,2, Celine Everaert1,2,3, Myrthala Moreno-Smith4, Liselot M Mus1,2, Eveline Barbieri4, Frank Speleman1,2, Pieter Mestdagh1,2,3, Jason Shohet4, Tom Van Maerken1,2, Jo Vandesompele1,2,3.
Abstract
The ongoing ascent of sequencing technologies has enabled researchers to gain unprecedented insights into the RNA content of biological samples. MiRNAs, a class of small non-coding RNAs, play a pivotal role in regulating gene expression. The discovery that miRNAs are stably present in circulation has spiked interest in their potential use as minimally-invasive biomarkers. However, sequencing of blood-derived samples (serum, plasma) is challenging due to the often low RNA concentration, poor RNA quality and the presence of highly abundant RNAs that dominate sequencing libraries. In murine serum for example, the high abundance of tRNA-derived small RNAs called 5' tRNA halves hampers the detection of other small RNAs, like miRNAs. We therefore evaluated two complementary approaches for targeted depletion of 5' tRNA halves in murine serum samples. Using a protocol based on biotinylated DNA probes and streptavidin coated magnetic beads we were able to selectively deplete 95% of the targeted 5' tRNA half molecules. This allowed an unbiased enrichment of the miRNA fraction resulting in a 6-fold increase of mapped miRNA reads and 60% more unique miRNAs detected. Moreover, when comparing miRNA levels in tumor-carrying versus tumor-free mice, we observed a three-fold increase in differentially expressed miRNAs.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27901112 PMCID: PMC5129013 DOI: 10.1038/srep37876
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Relative abundances of different small RNA species and tRNA-half types in libraries prepared using the NEBNext Multiplex Small RNA library prep kit, the TruSeq Small RNA library prep kit and the TailorMix miRNA sample preparation kit v2. Depicted values represent the amount of small RNA reads as a percentage of the mapped reads. Values represent the mean of two replicates. (b) Length distribution of the mapped reads detected in the NEBNext (red), TailorMix (grey) and TruSeq(blue) libraries.
Figure 2Schematic representation of the two investigated depletion protocols.
Beads-based depletion of 5′ tRNA halves involves the use of biotinylated DNA probes with complementarity to the 5′ tRNA half sequences. After DNA/RNA hybridization, probes are bound by magnetic streptavidin beads and immobilized using a magnetic field. Finally, the supernatant, containing purified RNA, is collected and purified by ethanol precipitation. RNase H-based depletion relies on the addition of complementary DNA probes followed by specific cleavage of RNA in DNA/RNA duplexes by RNase H. Remaining DNA probes are then degraded using DNAse I and the depleted RNA purified by ethanol precipitation. See methods section for a more detailed description.
Figure 3(a) tRNA depletion efficiency depicted as relative tRNA abundance values determined by RT-qPCR in non-depleted control samples, samples depleted of target tRNA-halves using RNase H and samples depleted of tRNA-halves using beads. Depicted values represent the mean of two replicates. Error bars represent the standard deviation of two replicates. (b) tRNA depletion efficiency depicted as relative tRNA abundance values determined by sequencing of depleted and non-depleted small RNA libraries. Depicted values represent the mean of three replicates. Error bars represent the standard deviation of three replicates.
Figure 4(a) Relative abundances of different small RNA species and tRNA-half types in depleted and non-depleted libraries. Depicted values represent the amount of small RNA reads as a percentage of the mapped reads. Values represent the mean of two replicates. (b) Length distribution of the mapped reads detected in libraries depleted using beads (grey), libraries depleted using RNase H (blue) and non-depleted libraries (red).
Sequencing output of non-depleted control samples, samples depleted using RNase H and samples depleted using beads.
| control | RNase H | beads | |
|---|---|---|---|
| mapped reads (millions) | 4.6 +/− 0.3 | 0.18 +/− 0.04 | 5.5 +/− 0.1 |
| total reads (millions) | 7.5 +/− 0.5 | 8.5 +/− 1.0 | 8.9 +/− 0.3 |
| mapped miRNAs reads (millions) | 0.26 +/− 0.04 | 0.0017 +/− 0.0002 | 1.91 +/− 0.05 |
| unique miRNAs | 240 +/− 9 | 40 +/− 5 | 417 +/− 6 |
Depicted values represent the mean of three samples +/− the standard error.
Figure 5Correlation of miRNA expression values in control samples versus depleted samples using beads (A) and RNase H (B). Expression values are depicted as log10 of the non-normalized counts. Depicted values represent the mean of three replicates. Red dots represent miRNAs that show (partial) complementarity with one of the used probes.
Figure 6Hierarchical clustering of samples based on significantly differentially expressed miRNAs in serum collected before tumor cell injection and after tumor manifestation.
Color areas indicate z-scores across all samples based on normalized miRNA expression values. (a) murine miRNAs in RNA depleted from 5′ tRNA halves; (b) human miRNAs in RNA depleted from 5′ tRNA halves. (c) murine miRNAs in non-depleted RNA. (d) human miRNAs in non-depleted RNA. miRNA names are according to miRBase v21 annotation.